Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.
Varicella-zoster virus encephalomyelitis with a prominent demyelinating component.
Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35-55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice.
Therapeutic Decisions in Multiple Sclerosis: Moving Beyond Efficacy.
Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis.
Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders.
The Gender Gap in Multiple Sclerosis: Intersection of Science and Society.
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptoms.
The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases.
Exploring myelin dysfunction in multiple system atrophy.
Toxic hepatitis after concomitant interferon beta and aloe vera treatment in a patient with multiple sclerosis: A case report.
Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.
Political notebook.
Costs of formal and informal home care and quality of life for patients with multiple sclerosis in sweden.
The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Predicting outcome in clinically isolated syndrome using machine learning.
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications.
Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination.
Clinical Nurse Specialist - A serious shortfall in numbers.
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
Pages
« first
‹ previous
…
454
455
456
457
458
459
460
461
462
…
next ›
last »